(Q46244463)

English

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

0 references

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

Dominique Figarella-Branger

13

object named as

Dominique Figarella-Branger

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

author name string

Philippe Metellus

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Carole Colin

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

David Taieb

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Eric Guedj

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Isabelle Nanni-Metellus

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Andre Maues de Paula

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Cécile Colavolpe

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Stephane Fuentes

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Henry Dufour

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Marylin Barrie

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Olivier Chinot

11

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

L'houcine Ouafik

12

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

publication date

5 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

105

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

591-600

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

https://scigraph.springernature.com/pub.10.1007/s11060-011-0625-2

0 references

Analysis of the IDH1 codon 132 mutation in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

FDG-PET as a prognostic factor in high-grade astrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Prediction of pathology and survival by FDG PET in gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Expression of hypoxia-inducible factor 1? in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

IDH1 mutations in gliomas: when an enzyme loses its grip

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Glioma-derived mutations in IDH: from mechanism to potential therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0625-2

21 January 2018

HIF-1 and human disease: one highly involved factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21643985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21643985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21643985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21643985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21643985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-011-0625-2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/21643985

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46244463&oldid=2102092343"